Ana I. Matos
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 3
- Immunology top 10%
- Immunotherapy and Immune Responses 11
- Pharmaceutical Science top 5%
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics 5
-
- Cancer Immunotherapy and Biomarkers 6
- CAR-T cell therapy research 3
-
- RNA Interference and Gene Delivery 5
- Advanced biosensing and bioanalysis techniques 3
- Chemical Synthesis and Analysis 2
In The Last Decade
Ana I. Matos
21 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 110
- Biomaterials 272
- Immunology 321
- Pharmaceutical Science 92
- Horticulture 9
- Biomedical Engineering 341
Countries citing papers authored by Ana I. Matos
This map shows the geographic impact of Ana I. Matos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana I. Matos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana I. Matos more than expected).
Fields of papers citing papers by Ana I. Matos
This network shows the impact of papers produced by Ana I. Matos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana I. Matos. The network helps show where Ana I. Matos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ana I. Matos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 8 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 15 | |
| 7 | 2021 | 33 | |
| 8 | 2020 | 5 | |
| 9 | 2019 | 187 | |
| 10 | 2019 | 52 | |
| 11 | 2018 | 27 | |
| 12 | 2018 | 8 | |
| 13 | 2017 | 7 | |
| 14 | 2017 | 37 | |
| 15 | 2017 | 75 | |
| 16 | 2016 | 102 | |
| 17 | 2015 | 2 | |
| 18 | 2015 | 253 | |
| 19 | 2015 | 60 | |
| 20 | Potencial alelopático e antioxidante de extratos vegetais | 2014 | 1 |
About Ana I. Matos
Ana I. Matos is a scholar working on Immunology, Oncology and Biomaterials, having authored 24 papers that have together received 1.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), Cancer Immunotherapy and Biomarkers (6 papers), RNA Interference and Gene Delivery (5 papers), Nanoplatforms for cancer theranostics (5 papers), CAR-T cell therapy research (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Nanoparticle-Based Drug Delivery (3 papers) and Chemical Synthesis and Analysis (2 papers). The work is most often cited by research in Biomaterials (272 citations), Immunology (321 citations) and Pharmaceutical Science (92 citations). Ana I. Matos has collaborated with scholars based in Portugal, Israel and Spain. Frequent co-authors include Helena F. Florindo, Carina Peres, Liane I.F. Moura, João Conniot, Vanessa Sainz, Rogério Gaspar, Liana C. Silva, Ronit Satchi‐Fainaro, Pedro M. P. Góis and Anna Scomparin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.